AlphaCrest Capital Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,390
| Closed | -$777K | – | 415 |
|
|
2022
Q3 | $777K | Sell |
2,390
-384
| -14% | -$125K | 0.05% | 760 |
|
|
2022
Q2 | $732K | Buy |
2,774
+1,940
| +233% | +$512K | 0.04% | 807 |
|
|
2022
Q1 | $251K | Buy |
+834
| New | +$251K | 0.01% | 1151 |
|
|
2021
Q3 | – | Sell |
-412
| Closed | -$274K | – | 1283 |
|
|
2021
Q2 | $274K | Buy |
+412
| New | +$274K | 0.01% | 1133 |
|
|
2020
Q4 | – | Sell |
-544
| Closed | -$559K | – | 1167 |
|
|
2020
Q3 | $559K | Buy |
+544
| New | +$559K | 0.06% | 529 |
|
|
2019
Q4 | – | Sell |
-384
| Closed | -$355K | – | 1283 |
|
|
2019
Q3 | $355K | Buy |
+384
| New | +$355K | 0.02% | 1053 |
|
|
2019
Q2 | – | Sell |
-208
| Closed | -$283K | – | 1059 |
|
|
2019
Q1 | $283K | Buy |
+208
| New | +$283K | 0.04% | 673 |
|